Molecular Diagnostics Infectious Disease Testing Market
Molecular Diagnostics Infectious Disease Testing
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Molecular Diagnostics Infectious Disease Testing
Market Size and Growth
The Molecular Diagnostics Infectious Disease Testing market is experiencing substantial growth, driven by rising demand for rapid, accurate testing methods. The market size is projected to reach approximately $6.5 billion by 2028. Increasing prevalence of infectious diseases and advancements in technology are key factors influencing market dynamics and expansion.
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ BD
◍ bioMérieux
◍ Thermo Fisher Scientific
◍ F. Hoffmann-La Roche
◍ Siemens AG
◍ Veridex
◍ Luminex
◍ GenMark Diagnostics
◍ Qiagen NV
◍ Genomix Biotech
◍ BioTheranostics
◍ GenMark Diagnostics
The Molecular Diagnostics Infectious Disease Testing Market is competitive, featuring companies like Abbott Laboratories, BD, bioMérieux, and Thermo Fisher Scientific. These firms innovate tests, enhance accuracy, and expand accessibility, driving market growth. Notable revenues include Abbott ($43 billion), Roche ($62 billion), and Thermo Fisher ($37 billion).
Request Sample Report
Market Segmentation
By Application
Hospital
Laboratory Research
By Product
◍ Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
